Progress of artificial intelligence for science (AI4S) applications in drug development and clinical practice in the digital age
- VernacularTitle:人工智能驱动的科学研究（AI4S）在药物研发与临床实践中的应用进展
- Author:
Chunli ZHANG
1
;
Gang NIU
1
Author Information
1. 1. Turing-Darwin Laboratory, Beijing, 100190, P. R. China 2. Western Institute of Computing Technology, Chongqing, 400000, P. R. China
- Publication Type:Journal Article
- Keywords:
Artificial intelligence for science;
digital twins;
electronic drugs;
virtual clinical trials
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2024;31(10):1392-1399
- CountryChina
- Language:Chinese
-
Abstract:
Artificial intelligence (AI) for science (AI4S) technology, the AI technology for scientific research, has shown tremendous potential and influence in the field of healthcare, redefining the research paradigm of medical science under the guidance of computational medicine. We reviewed the main technological trends of AI4S in reshaping healthcare paradigm: knowledge-driven AI, leveraging extensive literature mining and data integration, emerges an important tool for understanding disease mechanisms and facilitating novel drug development; data-driven AI, delving into clinical and human-related omics data, unveils individual variances and disease mechanisms, and further establishes patient-centric digital twins to guide drug development and personalized medicine. Meanwhile, based on authentic patient digital twin models, adaptable strategies are employed to further propel the development of "e-drugs" that mimic the authentic mechanisms. These digital twins of drugs are evaluated for drug efficacy and safety through large-scale cloud-based virtual clinical trials, and followed by rationally designed real-world clinical trials, thus notably reducing drug development costs and enhancing success rates. Despite encountering challenges such as data scale, quality control, model interpretability, the transition from science insights to engineering solutions, and regulatory hurdles, we anticipate the integration of AI4S technology to revolutionize drug development and clinical practices. This transformation brings revolutionary changes to the medical field, offering novel opportunities and challenges for the development of medical science, and more importantly, providing necessary but personalized healthcare solutions for humankind.
